drugset / Trial / NCT04612790
A Study to Investigate the Use of Benralizumab in Patients With Bullous Pemphigoid.
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to investigate the use of benralizumab is effective in the treatment of patients symptomatic Bullous Pemphigoid (BP).
Timeline
- Start
- 2021-03-31
- Primary completion
- 2023-10-26
- Completion
- 2023-10-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Benralizumab | Monoclonal antibody | — | Subcutaneous |